OCPP, LLC
Letter data
- Company
- OCPP, LLC
- Recipient
- Olivia K.L. Hudson | Owner | OCPP, LLC | OC Raw Dog LLC | 1500 Commerce Street, Suite 101 | Corona | , | CA | 72878-3215 | United States | olivia@ocpp.pet
- Issue date
- 2026-05-21
- Posted date
- Not available
- FDA office
- Office of Human and Animal Food Operations- West Division 5
- Subject
- Not available
- Product
- Animal & Veterinary
- CMS ID
- 615550
- Reference number
- Not available
- FEI
- Not available
- Inspection dates
- Not available
Normalized citations
21 CFR: None found
21 U.S.C.: None found
Related FDA links
No related FDA letter link is present in the source index.
Full source text
CLOSEOUT LETTER
OCPP, LLC
MARCS-CMS 615550 —
May 21, 2026
More Warning Letters
Warning Letters
About Warning and Close-Out Letters
Delivery Method:
VIA EMAIL NO HARD COPY TO FOLLOW
Product:
Animal & Veterinary
Recipient:
Recipient Name
Olivia K.L. Hudson
Recipient Title
Owner
OCPP, LLC
OC Raw Dog LLC
1500 Commerce Street, Suite 101
Corona
,
CA
72878-3215
United States
olivia@ocpp.pet
Issuing Office:
Office of Human and Animal Food Operations- West Division 5
United States
Secondary Issuing Offices
United States
Dear Olivia Hudson,
The United States Food and Drug Administration has completed evaluation of your facility’s corrective actions in response to our Warning Letter CMS 615550, dated February 23, 2022. Based on our evaluation, it appears that you have addressed the violations contained in this Warning Letter. Future FDA inspections and regulatory activities will further assess the adequacy and sustainability of these corrections.
This letter does not relieve you or your facility from the responsibility of taking all necessary steps to assure sustained compliance with the Federal Food, Drug, and Cosmetic Act and its implementing regulations or with other relevant legal authority. The Agency expects you and your facility to maintain compliance and will continue to monitor your state of compliance. This letter will not preclude any future regulatory action should violations be observed during a subsequent inspection or through other means.
Sincerely,
/S/
Stephen J. Rabe
Compliance Officer, Office of Surveillance and Compliance
Center for Veterinary Medicine
U.S. Food and Drug Administration
Tel: 513-322-0660
Content current as of:
05/21/2026
Regulated Product(s)
Animal & Veterinary